Eosinophil progenitors in allergy and asthma — Do they matter?

Asquith, 2008, The IL-3/IL-5/GM-CSF common receptor plays a pivotal role in the regulation of Th2 immunity and allergic airway inflammation, J Immunol, 180, 1199, 10.4049/jimmunol.180.2.1199 Baatjes, 2002, Anti-allergic therapies: effects on eosinophil progenitors, Pharmacol Ther, 95, 63, 10.1016/S0163-7258(02)00233-4 Bautz, 2001, Chemotaxis and transendothelial migration of CD34(+) hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1, Blood, 97, 3433, 10.1182/blood.V97.11.3433 Beasley, 2000, Prevalence and etiology of asthma, J Allergy Clin Immunol, 105, S466, 10.1016/S0091-6749(00)90044-7 Bochner, 1994, The role of adhesion molecules in human eosinophil and basophil recruitment, J Allergy Clin Immunol, 94, 427, 10.1016/0091-6749(94)90195-3 Braccioni, 2002, The effect of cysteinyl leukotrienes on growth of eosinophil progenitors from peripheral blood and bone marrow of atopic subjects, J Allergy Clin Immunol, 110, 96, 10.1067/mai.2002.125000 Broide, 1992, Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics, J Clin Invest, 90, 1414, 10.1172/JCI116008 Cameron, 2000, Evidence for local eosinophil differentiation within allergic nasal mucosa: inhibition with soluble IL-5 receptor, J Immunol, 164, 1538, 10.4049/jimmunol.164.3.1538 Chae, 2004, Analysis of the polymorphisms in eotaxin gene family and their association with asthma, IgE, and eosinophil, Biochem Biophys Res Commun, 320, 131, 10.1016/j.bbrc.2004.05.136 Chae, 2005, The suggestive association of eotaxin-2 and eotaxin-3 gene polymorphisms in Korean population with allergic rhinitis, Immunogenetics, 56, 760, 10.1007/s00251-004-0746-2 Coffman, 1989, Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice, Science, 245, 308, 10.1126/science.2787531 Collins, 1995, Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo, J Exp Med, 182, 1169, 10.1084/jem.182.4.1169 Cromwell, 1988, Leukotriene C4 generation from human eosinophils stimulated with IgG-Aspergillus fumigatus antigen immune complexes, J Allergy Clin Immunol, 82, 535, 10.1016/0091-6749(88)90962-1 Daugherty, 1996, Cloning, expression, and characterization of the human eosinophil eotaxin receptor, J Exp Med, 183, 2349, 10.1084/jem.183.5.2349 De Lucca, 2005, Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency, J Med Chem, 48, 2194, 10.1021/jm049530m Denburg, 2000, Systemic aspects of allergic disease: bone marrow responses, J Allergy Clin Immunol,, 106, S242, 10.1067/mai.2000.110156 Denburg, 1994, Basophil and eosinophil differentiation in allergic reactions, J Allergy Clin Immunol, 94, 1135, 10.1016/0091-6749(94)90321-2 Dent, 2004, Contribution of eotaxin-1 to eosinophil chemotactic activity of moderate and severe asthmatic sputum, Am J Respir Crit Care Med, 169, 1110, 10.1164/rccm.200306-855OC Ding, 2004, Bertilimumab Cambridge Antibody Technology Group, Curr Opin Investig Drugs, 5, 1213 Dorman, 2005, Progenitor egress from the bone marrow after allergen challenge: role of stromal cell-derived factor 1alpha and eotaxin, J Allergy Clin Immunol, 115, 501, 10.1016/j.jaci.2004.11.017 Dorman, 2004, Kinetics of bone marrow eosinophilopoiesis and associated cytokines after allergen inhalation, Am J Respir Crit Care Med, 169, 565, 10.1164/rccm.200307-1024OC Fairbairn, 1993, Suppression of apoptosis allows differentiation and development of a multipotent hemopoietic cell line in the absence of added growth factors, Cell, 74, 823, 10.1016/0092-8674(93)90462-Y Farahi, 2007, Eotaxin-1/CC chemokine ligand 11: a novel eosinophil survival factor secreted by human pulmonary artery endothelial cells, J Immunol, 179, 1264, 10.4049/jimmunol.179.2.1264 Flood-Page, 2003, Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway, Am J Respir Crit Care Med, 167, 199, 10.1164/rccm.200208-789OC Flood-Page, 2003, Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics, J Clin Invest, 112, 1029, 10.1172/JCI17974 Forssmann, 1997, Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes, J Exp Med, 185, 2171, 10.1084/jem.185.12.2171 Foster, 1996, Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model, J Exp Med, 183, 195, 10.1084/jem.183.1.195 Foster, 2002, Interleukins-4, -5, and -13: emerging therapeutic targets in allergic disease, Pharmacol Ther, 94, 253, 10.1016/S0163-7258(02)00220-6 Foster, 2001, Elemental signals regulating eosinophil accumulation in the lung, Immunol Rev, 179, 173, 10.1034/j.1600-065X.2001.790117.x Fryer, 2000, The -403 G->A promoter polymorphism in the RANTES gene is associated with atopy and asthma, Genes Immun, 1, 509, 10.1038/sj.gene.6363717 Fujishima, 2005, Prostaglandin D2 induces chemotaxis in eosinophils via its receptor CRTH2 and eosinophils may cause severe ocular inflammation in patients with allergic conjunctivitis, Cornea, 24, 66, 10.1097/01.ico.0000178733.42921.4c Fulkerson, 2006, A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation, Proc Natl Acad Sci U S A, 103, 16418, 10.1073/pnas.0607863103 Garrett, 2004, Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes, J Allergy Clin Immunol, 113, 115, 10.1016/j.jaci.2003.10.049 Gaspar Elsas, 1997, Rapid increase in bone-marrow eosinophil production and responses to eosinopoietic interleukins triggered by intranasal allergen challenge, Am J Respir Cell Mol Biol, 17, 404, 10.1165/ajrcmb.17.4.2691 Gauvreau, 2000, The effects of inhaled budesonide on circulating eosinophil progenitors and their expression of cytokines after allergen challenge in subjects with atopic asthma, Am J Respir Crit Care Med, 162, 2139, 10.1164/ajrccm.162.6.2001120 Gibson, 1990, The inflammatory response in asthma exacerbation: changes in circulating eosinophils, basophils and their progenitors, Clin Exp Allergy, 20, 661, 10.1111/j.1365-2222.1990.tb02705.x Gibson, 1991, Allergen-induced asthmatic responses. Relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils, and their progenitors, Am Rev Respir Dis, 143, 331, 10.1164/ajrccm/143.2.331 Gibson, 1992, A research method to induce and examine a mild exacerbation of asthma by withdrawal of inhaled corticosteroid, Clin Exp Allergy, 22, 525, 10.1111/j.1365-2222.1992.tb00161.x Gleich, 1986, The eosinophilic leukocyte: structure and function, Adv Immunol, 39, 177, 10.1016/S0065-2776(08)60351-X Gleich, 1984, Immunobiology of eosinophils, Annu Rev Immunol, 2, 429, 10.1146/annurev.iy.02.040184.002241 Gleich, 1979, Cytotoxic properties of the eosinophil major basic protein, J Immunol, 123, 2925, 10.4049/jimmunol.123.6.2925 Gregory, 2003, Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor alpha-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor alpha expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor alpha expression, J Immunol, 170, 5359, 10.4049/jimmunol.170.11.5359 Hamelmann, 2001, IL-5-induced airway eosinophilia—the key to asthma?, Immunol Rev, 179, 182, 10.1034/j.1600-065X.2001.790118.x Hirai, 2001, Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2, J Exp Med, 193, 255, 10.1084/jem.193.2.255 Hogan, 1997, Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice, Immunol Cell Biol, 75, 284, 10.1038/icb.1997.43 Hogan, 1998, Interleukin-5-producing CD4+ T cells play a pivotal role in aeroallergen-induced eosinophilia, bronchial hyperreactivity, and lung damage in mice, Am J Respir Crit Care Med, 157, 210, 10.1164/ajrccm.157.1.9702074 Hogan, 2000, IL-5 production by bone marrow stromal cells: implications for eosinophilia associated with asthma, J Allergy Clin Immunol, 106, 329, 10.1067/mai.2000.108309 Hogan, 2003, Regulation of eosinophilopoiesis in a murine model of asthma, J Immunol, 171, 2644, 10.4049/jimmunol.171.5.2644 Humbles, 1997, Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo, J Exp Med, 186, 601, 10.1084/jem.186.4.601 Humbles, 2002, The murine CCR3 receptor regulates both the role of eosinophils and mast cells in allergen-induced airway inflammation and hyperresponsiveness, Proc Natl Acad Sci U S A, 99, 1479, 10.1073/pnas.261462598 Inman, 1996, Allergen-induced increase in bone marrow progenitors in airway hyperresponsive dogs: regulation by a serum hemopoietic factor, Am J Respir Cell Mol Biol, 15, 305, 10.1165/ajrcmb.15.3.8924277 Inman, 1999, Allergen-induced increase in airway responsiveness, airway eosinophilia, and bone-marrow eosinophil progenitors in mice, Am J Respir Cell Mol Biol, 21, 473, 10.1165/ajrcmb.21.4.3622 Iwasaki, 2005, Identification of eosinophil lineage-committed progenitors in the murine bone marrow, J Exp Med, 201, 1891, 10.1084/jem.20050548 Jacoby, 1993, Human eosinophil major basic protein is an endogenous allosteric antagonist at the inhibitory muscarinic M2 receptor, J Clin Invest, 91, 1314, 10.1172/JCI116331 Johansson, 2004, Allergen stimulates bone marrow CD34(+) cells to release IL-5 in vitro; a mechanism involved in eosinophilic inflammation?, Allergy, 59, 1080, 10.1111/j.1398-9995.2004.00596.x Jose, 1994, Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs, Biochem Biophys Res Commun, 205, 788, 10.1006/bbrc.1994.2734 Jose, 1994, Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation, J Exp Med, 179, 881, 10.1084/jem.179.3.881 Kay, 2004, Anti-interleukin-5 therapy for asthma and hypereosinophilic syndrome, Immunol Allergy Clin North Am, 24, 645, 10.1016/j.iac.2004.06.007 Kim, 1997, Stem cell factor in nasal polyposis and allergic rhinitis: increased expression by structural cells is suppressed by in vivo topical corticosteroids, J Allergy Clin Immunol, 100, 389, 10.1016/S0091-6749(97)70254-9 Kim, 1999, Immunolocalization of CD34 in nasal polyposis. Effect of topical corticosteroids, Am J Respir Cell Mol Biol, 20, 388, 10.1165/ajrcmb.20.3.3060 Kips, 2003, Effect of SCH55700, a humanized anti-human interleukin-5 antibody, in severe persistent asthma: a pilot study, Am J Respir Crit Care Med, 167, 1655, 10.1164/rccm.200206-525OC Kita, 1996, The eosinophil: a cytokine-producing cell?, J Allergy Clin Immunol, 97, 889, 10.1016/S0091-6749(96)80061-3 Koury, 1992, Programmed cell death (apoptosis) in hematopoiesis, Exp Hematol, 20, 391 Krause, 1996, CD34: structure, biology, and clinical utility, Blood, 87, 1, 10.1182/blood.V87.1.1.1 Kucia, 2004, CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion, J Mol Histol, 35, 233, 10.1023/B:HIJO.0000032355.66152.b8 Kuo, 2001, Interleukin-5 in growth and differentiation of blood eosinophil progenitors in asthma: effect of glucocorticoids, Br J Pharmacol, 134, 1539, 10.1038/sj.bjp.0704389 Lamkhioued, 2003, The CCR3 receptor is involved in eosinophil differentiation and is up-regulated by Th2 cytokines in CD34+ progenitor cells, J Immunol, 170, 537, 10.4049/jimmunol.170.1.537 Lanza, 2001, Structural and functional features of the CD34 antigen: an update, J Biol Regul Homeost Agents, 15, 1 Leckie, 2000, Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response, Lancet, 356, 2144, 10.1016/S0140-6736(00)03496-6 Lee, 1997, Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma, J Exp Med, 185, 2143, 10.1084/jem.185.12.2143 Levesque, 2003, Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide, J Clin Invest, 111, 187, 10.1172/JCI15994 Lim, 1995, Human eosinophils release the lymphocyte and eosinophil active cytokines, RANTES and lymphocyte chemoattractant factor, Int Arch Allergy Immunol, 107, 342, 10.1159/000237023 Liu, 2002, Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge, J Immunol, 169, 6452, 10.4049/jimmunol.169.11.6452 Liu, 2002, Decreased expression of membrane IL-5 receptor alpha on human eosinophils: II. IL-5 down-modulates its receptor via a proteinase-mediated process, J Immunol, 169, 6459, 10.4049/jimmunol.169.11.6459 Lopez, 1986, Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells, J Exp Med, 163, 1085, 10.1084/jem.163.5.1085 Lopez, 1986, Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival, J Clin Invest, 78, 1220, 10.1172/JCI112705 Ma, 2002, CCR3 is essential for skin eosinophilia and airway hyperresponsiveness in a murine model of allergic skin inflammation, J Clin Invest, 109, 621, 10.1172/JCI0214097 Makowska, 2008, Systemic responses after bronchial aspirin challenge in sensitive patients with asthma, J Allergy Clin Immunol, 121, 348, 10.1016/j.jaci.2007.09.039 Mathur, 1999, TRFK-5 reverses established airway eosinophilia but not established hyperresponsiveness in a murine model of chronic asthma, Am J Respir Crit Care Med, 159, 580, 10.1164/ajrccm.159.2.9712018 Mayani, 1992, Biology of the hemopoietic microenvironment, Eur J Haematol, 49, 225, 10.1111/j.1600-0609.1992.tb00053.x McNagny, 2002, Making eosinophils through subtle shifts in transcription factor expression, J Exp Med, 195, F43, 10.1084/jem.20020636 McNagny, 1998, Regulation of eosinophil-specific gene expression by a C/EBP-Ets complex and GATA-1, Embo J, 17, 3669, 10.1093/emboj/17.13.3669 Menzies-Gow, 2007, Effect of inhaled interleukin-5 on eosinophil progenitors in the bronchi and bone marrow of asthmatic and non-asthmatic volunteers, Clin Exp Allergy, 37, 1023, 10.1111/j.1365-2222.2007.02735.x Menzies-Gow, 2003, Anti-IL-5 (mepolizumab) therapy induces bone marrow eosinophil maturational arrest and decreases eosinophil progenitors in the bronchial mucosa of atopic asthmatics, J Allergy Clin Immunol, 111, 714, 10.1067/mai.2003.1382 Menzies-Gow, 2002, Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers, J Immunol, 169, 2712, 10.4049/jimmunol.169.5.2712 Minshall, 1998, Interleukin-5 expression in the bone marrow of sensitized Balb/c mice after allergen challenge, Am J Respir Crit Care Med, 158, 951, 10.1164/ajrccm.158.3.9709114 Miyahara, 2005, Requirement for leukotriene B4 receptor 1 in allergen-induced airway hyperresponsiveness, Am J Respir Crit Care Med, 172, 161, 10.1164/rccm.200502-205OC Mould, 1997, Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice, J Clin Invest, 99, 1064, 10.1172/JCI119234 Murali, 1997, Development of bone marrow eosinophilia in mice induced by Aspergillus fumigatus antigens, Clin Immunol Immunopathol, 84, 216, 10.1006/clin.1997.4392 Nakamura, 2001, Variant eotaxin: its effects on the asthma phenotype, J Allergy Clin Immunol, 108, 946, 10.1067/mai.2001.120135 O'Byrne, 2001, The trials and tribulations of IL-5, eosinophils, and allergic asthma, J Allergy Clin Immunol, 108, 503, 10.1067/mai.2001.119149 Ohkawara, 1997, Cytokine and eosinophil responses in the lung, peripheral blood, and bone marrow compartments in a murine model of allergen-induced airways inflammation, Am J Respir Cell Mol Biol, 16, 510, 10.1165/ajrcmb.16.5.9160833 Otsuka, 1986, Basophilic cell progenitors, nasal metachromatic cells, and peripheral blood basophils in ragweed-allergic patients, J Allergy Clin Immunol, 78, 365, 10.1016/S0091-6749(86)80091-4 Palframan, 1998, Mechanisms of acute eosinophil mobilization from the bone marrow stimulated by interleukin 5: the role of specific adhesion molecules and phosphatidylinositol 3-kinase, J Exp Med, 188, 1621, 10.1084/jem.188.9.1621 Palframan, 1998, Eotaxin induces a rapid release of eosinophils and their progenitors from the bone marrow, Blood, 91, 2240, 10.1182/blood.V91.7.2240 Parameswaran, 2004, The effect of pranlukast on allergen-induced bone marrow eosinophilopoiesis in subjects with asthma, Am J Respir Crit Care Med, 169, 915, 10.1164/rccm.200312-1645OC Phipps, 2007, Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus, Blood, 110, 1578, 10.1182/blood-2007-01-071340 Piliponsky, 2001, Human eosinophils induce histamine release from antigen-activated rat peritoneal mast cells: a possible role for mast cells in late-phase allergic reactions, J Allergy Clin Immunol, 107, 993, 10.1067/mai.2001.114656 Plotz, 2003, Use of an anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis, N Engl J Med, 349, 2334, 10.1056/NEJMoa031261 Ponath, 1996, Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils, J Exp Med, 183, 2437, 10.1084/jem.183.6.2437 Pope, 2005, The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia, J Immunol, 175, 5341, 10.4049/jimmunol.175.8.5341 Radinger, 2007, Regulation of allergen-induced bone marrow eosinophilopoiesis: role of CD4(+) and CD8(+) T cells, Allergy, 62, 1410, 10.1111/j.1398-9995.2007.01509.x Radinger, 2004, Eotaxin-2 regulates newly produced and CD34 airway eosinophils after allergen exposure, J Allergy Clin Immunol, 113, 1109, 10.1016/j.jaci.2004.03.022 Radinger, 2006, Regulatory role of CD8+ T lymphocytes in bone marrow eosinophilopoiesis, Respir Res, 7, 83, 10.1186/1465-9921-7-83 Rankin, 2000, Eotaxin and eosinophil recruitment: implications for human disease, Mol Med Today, 6, 20, 10.1016/S1357-4310(99)01635-4 Ravensberg, 2005, Eotaxin-2 and eotaxin-3 expression is associated with persistent eosinophilic bronchial inflammation in patients with asthma after allergen challenge, J Allergy Clin Immunol, 115, 779, 10.1016/j.jaci.2004.11.045 Robinson, 1999, CD34(+)/interleukin-5Ralpha messenger RNA+ cells in the bronchial mucosa in asthma: potential airway eosinophil progenitors, Am J Respir Cell Mol Biol, 20, 9, 10.1165/ajrcmb.20.1.3449 Robinson, 1999, Eosinophil development and bone marrow and tissue eosinophils in atopic asthma, Int Arch Allergy Immunol, 118, 98, 10.1159/000024039 Rosenberg, 2001, Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens, J Leukoc Biol, 70, 691, 10.1189/jlb.70.5.691 Rosenberg, 2007, Eosinophil trafficking in allergy and asthma, J Allergy Clin Immunol, 119, 1303, 10.1016/j.jaci.2007.03.048 Rothenberg, 1998, Eosinophilia, N Engl J Med, 338, 1592, 10.1056/NEJM199805283382206 Rothenberg, 1995, Constitutive and allergen-induced expression of eotaxin mRNA in the guinea pig lung, J Exp Med, 181, 1211, 10.1084/jem.181.3.1211 Saito, 2004, Effects of a cysteinyl leukotriene receptor antagonist on eosinophil recruitment in experimental allergic rhinitis, Immunology, 113, 246, 10.1111/j.1365-2567.2004.01944.x Sanderson, 1992, Interleukin-5, eosinophils, and disease, Blood, 79, 3101, 10.1182/blood.V79.12.3101.bloodjournal79123101 Sehmi, 2003, Allergen-induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation, Immunology, 109, 536, 10.1046/j.1365-2567.2003.01686.x Sehmi, 1996, Increased levels of CD34+ hemopoietic progenitor cells in atopic subjects, Am J Respir Cell Mol Biol, 15, 645, 10.1165/ajrcmb.15.5.8918371 Sehmi, 1997, Allergen-induced increases in IL-5 receptor alpha-subunit expression on bone marrow-derived CD34+ cells from asthmatic subjects. A novel marker of progenitor cell commitment towards eosinophilic differentiation, J Clin Invest, 100, 2466, 10.1172/JCI119789 Sergejeva, 2004, Allergen exposure-induced differences in CD34+ cell phenotype: relationship to eosinophilopoietic responses in different compartments, Blood, 103, 1270, 10.1182/blood-2003-05-1618 Sergejeva, 2005, Increased number of CD34+ cells in nasal mucosa of allergic rhinitis patients: inhibition by a local corticosteroid, Clin Exp Allergy, 35, 34, 10.1111/j.1365-2222.2004.02038.x Shalit, 1995, Modulation of growth and differentiation of eosinophils from human peripheral blood CD34+ cells by IL5 and other growth factors, Cell Immunol, 160, 50, 10.1016/0008-8749(95)80008-7 Shaw, 1984, Preferential generation of leukotriene C4 by human eosinophils, Clin Exp Immunol, 56, 716 Shinagawa, 2003, Involvement of CCR3-reactive chemokines in eosinophil survival, Int Arch Allergy Immunol, 130, 150, 10.1159/000069005 Shinkai, 1999, A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils, J Immunol, 163, 1602, 10.4049/jimmunol.163.3.1602 Sitkauskiene, 2004, Regulation of bone marrow and airway CD34+ eosinophils by interleukin-5, Am J Respir Cell Mol Biol, 30, 367, 10.1165/rcmb.2002-0311OC Southam, 2005, Increased eosinophil-lineage committed progenitors in the lung of allergen-challenged mice, J Allergy Clin Immunol, 115, 95, 10.1016/j.jaci.2004.09.022 Stevenson, 2006, Clinical and pathologic perspectives on aspirin sensitivity and asthma, J Allergy Clin Immunol, 118, 773, 10.1016/j.jaci.2006.07.024 Szilvassy, 1995, Enriched hematopoietic stem cells: basic biology and clinical utility, Biol Blood Marrow Transplant, 1, 3 Tager, 2000, BLTR mediates leukotriene B(4)-induced chemotaxis and adhesion and plays a dominant role in eosinophil accumulation in a murine model of peritonitis, J Exp Med, 192, 439, 10.1084/jem.192.3.439 Tomaki, 2000, Eosinophilopoiesis in a murine model of allergic airway eosinophilia: involvement of bone marrow IL-5 and IL-5 receptor alpha, J Immunol, 165, 4040, 10.4049/jimmunol.165.7.4040 Ueda, 2003, Leukotriene receptor antagonist pranlukast suppresses eosinophil infiltration and cytokine production in human nasal mucosa of perennial allergic rhinitis, Ann Otol Rhinol Laryngol, 112, 955, 10.1177/000348940311201107 Vadas, 1994, Cytokines and allergy, J Allergy Clin Immunol, 94, 1289, 10.1016/0091-6749(94)90344-1 Wang, 2007, Airway eosinophils: allergic inflammation recruited professional antigen-presenting cells, J Immunol, 179, 7585, 10.4049/jimmunol.179.11.7585 Wang, 1998, Circulating, but not local lung, IL-5 is required for the development of antigen-induced airways eosinophilia, J Clin Invest, 102, 1132, 10.1172/JCI2686 Wegmann, 2007, Effects of a low-molecular-weight CCR-3 antagonist on chronic experimental asthma, Am J Respir Cell Mol Biol, 36, 61, 10.1165/rcmb.2006-0188OC Weller, 1994, Eosinophils: structure and functions, Curr Opin Immunol, 6, 85, 10.1016/0952-7915(94)90038-8 Woerly, 1999, Expression of Th1 and Th2 immunoregulatory cytokines by human eosinophils, Int Arch Allergy Immunol, 118, 95, 10.1159/000024038 Woltmann, 2000, Interleukin-13 induces PSGL-1/P-selectin-dependent adhesion of eosinophils, but not neutrophils, to human umbilical vein endothelial cells under flow, Blood, 95, 3146, 10.1182/blood.V95.10.3146 Wood, 1998, Allergen challenge increases cell traffic between bone marrow and lung, Am J Respir Cell Mol Biol, 18, 759, 10.1165/ajrcmb.18.6.3006 Wood, 1998, Changes in bone marrow inflammatory cell progenitors after inhaled allergen in asthmatic subjects, Am J Respir Crit Care Med, 157, 99, 10.1164/ajrccm.157.1.9704125 Wood, 2002, Allergen-induced increases in bone marrow T lymphocytes and interleukin-5 expression in subjects with asthma, Am J Respir Crit Care Med, 166, 883, 10.1164/rccm.2108015 Wood, 1999, An inhaled corticosteroid, budesonide, reduces baseline but not allergen-induced increases in bone marrow inflammatory cell progenitors in asthmatic subjects, Am J Respir Crit Care Med, 159, 1457, 10.1164/ajrccm.159.5.9808123 Woolley, 1994, Allergen-induced changes in bone marrow progenitors and airway responsiveness in dogs and the effect of inhaled budesonide on these parameters, Am J Respir Cell Mol Biol, 11, 600, 10.1165/ajrcmb.11.5.7946389 Wright, 2002, Hematopoietic stem cells are uniquely selective in their migratory response to chemokines, J Exp Med, 195, 1145, 10.1084/jem.20011284 Ying, 1997, Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics, J Immunol, 158, 3539, 10.4049/jimmunol.158.7.3539 Ying, 1999, Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (Intrinsic) asthmatics, J Immunol, 163, 6321, 10.4049/jimmunol.163.11.6321 Ying, 1999, C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES), J Immunol, 163, 3976, 10.4049/jimmunol.163.7.3976 Yu, 2002, Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo, J Exp Med, 195, 1387, 10.1084/jem.20020656 Zeibecoglou, 1999, Increased mature and immature CCR3 messenger RNA+ eosinophils in bone marrow from patients with atopic asthma compared with atopic and nonatopic control subjects, J Allergy Clin Immunol, 103, 99, 10.1016/S0091-6749(99)70532-4 Zimmermann, 2003, Chemokines in asthma: cooperative interaction between chemokines and IL-13, J Allergy Clin Immunol, 111, 227, 10.1067/mai.2003.139 Zimmermann, 2000, Murine eotaxin-2: a constitutive eosinophil chemokine induced by allergen challenge and IL-4 overexpression, J Immunol, 165, 5839, 10.4049/jimmunol.165.10.5839